The Living Urn Significantly Expands Its Pet Urn and Keepsake Offering
The company is excited to introduce its new and unique ceramic, wood, and metal pet urns, keepsakes, and cremation jewelry.
'We expect that our new pet urn and keepsake options will be quickly adopted by pet families nationwide and will help us accelerate our growth in this market.' — Mark Brewer, President
GREENWOOD VIILLAGE, CO, UNITED STATES, March 27, 2025 / EINPresswire.com / -- The Living Urn, a division Biolife, LLC, is excited to announce that it has significantly expanded its pet options to include over 20 new metal and ceramic urns, new and unique ceramic, wood, and metal keepsakes, and sterling silver pet cremation jewelry.
Mark Brewer, company President, commented, 'We're extremely excited about the expansion of our pet business and our new and unique urns, keepsakes, and jewelry. This includes an entire line of metal urns designed for pets and pet keepsakes such as the Memories Paw Print Photo Frame and Cuddle Stones for Pets.
Brewer continues, 'We expect that our new pet urn and keepsake options will be quickly adopted by pet families nationwide and will help us accelerate our growth in this market.'
The Living Urn's new pet urns, keepsakes and jewelry are available online and soon at a pet cremation provider near you.
About The Living Urn
Based in Colorado, The Living Urn is committed to developing and providing unique cremation urns, keepsakes, and cremation jewelry serving families looking for afterlife options that can be more meaningful and personal. Its growing market leading product offering includes the patented Living Urn®, the leading bio urn and planting system designed to grow a tree with cremated remains, The Living Urn® Indoors, the Eco Scattering Urn, a unique bamboo urn for scattering ashes, the Eco Water Urn, a proprietary urn that floats and gracefully frees ashes in water, and the Eco Burial Urn, a special bamboo burial or traditional decorative urn. The company is developing additional proprietary cremation urns and keepsake urns that it will be introducing in the next few months.
Biolife, LLC
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the appointments of Mr. David Roberts and Mr. Gregory Moss to its Board of Directors. The Company also announced the resignation of Dr. Wenyi Gu from the Board upon completion of his term as an Australia-based non-executive director. 'On behalf of the management team and Board, I am delighted to welcome David and Gregory to the Company' commented John Seaberg, Chairman of Anteris. 'On the heels of our Q4 2024 listing onto NASDAQ, and as we ramp-up activities to launch the DurAVR® THV global, pivotal clinical trial (the "PARADIGM Trial"), we are excited to enhance the leadership team with two highly accomplished, U.S. based, healthcare executives as the company transitions to its next phase of growth. I also wish to extend gratitude to Dr. Gu for his commitment and contributions to the company over the course of his tenure as a member of the Board and wish him well on his future endeavors.' Mr. David Roberts is currently President of LeMaitre Vascular, Inc. (NASDAQ: LMAT), a position he has held since 2007. He joined LeMaitre in 1997 as Vice President of Business Development and was promoted to Chief Financial Officer in 2000. Prior to LeMaitre, Mr. Roberts served as Vice President of Development for BUCA, Inc. from 1994 to 1997, and prior to that as Associate of HarbourVest Partners from 1992 to 1994. Mr. Roberts received a Bachelor of Arts in Business Economics and History from Brown University and a Master of Business Administration from the Stanford University Graduate School of Business. Mr. Roberts serves as a director of LeMaitre Vascular, Inc., Lexington Medical, Inc. and Parasole Restaurant Holdings, Inc. Mr. Gregory Moss serves as Chief Business and Legal Officer, as well as Corporate Secretary and Chief Compliance Officer of Evommune, Inc. Prior to Evommune, Mr. Moss served as Executive Vice President, General Counsel, and Corporate Secretary, Chief Compliance Officer at Kadmon, a Sanofi Company, where he led legal, compliance, and business development operations, culminating in Kadmon's $1.9 billion acquisition in 2021. Prior to joining Kadmon in 2012, Mr. Moss served as a solicitor in the corporate risk department of a large Australian law firm and as an associate at a boutique law firm and hedge fund in New York, where he focused on complex litigation and event-driven outcomes. Mr. Moss currently serves on the board of Vitls, Inc. Mr. Moss earned a BA and an LLB from Macquarie University, Australia, and is a member of the Bar Associations of New York, USA, and New South Wales, Australia, with admissions before the Supreme Court of the United States of America; Southern District of New York; Supreme Court of New South Wales, Australia; and High Court of Australia. Mr. Roberts and Mr. Moss will help guide Anteris through its next phase of growth, with the upcoming global pivotal PARADIGM study in 3Q2025 towards the ultimate U.S. and EMA licensure of the DurAVR® THV for patients with aortic stenosis. About Anteris Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients. Anteris' lead product, the DurAVR® Transcatheter Heart Valve (THV), was designed in partnership with the world's leading interventional cardiologists and cardiac surgeons to treat aortic stenosis – a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR® THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. DurAVR® THV is made using a single piece of molded ADAPT® tissue, Anteris' patented anti-calcification tissue technology. ADAPT® tissue, which is FDA-cleared, has been used clinically for over 10 years and distributed for use in over 55,000 patients worldwide. The DurAVR® THV System is comprised of the DurAVR® valve, the ADAPT® tissue, and the balloon-expandable ComASUR® Delivery System. For more information: Investor Relations investor@ OrmsbyAnteris Technologies Global Corp.+61 1300 550 310 | +61 7 3152 3200 Investor Relations (US)mchatterjee@ Chatterjee, Life Science Group+1 917 330 4269WebsiteXFacebookLinkedIn in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the appointments of Mr. David Roberts and Mr. Gregory Moss to its Board of Directors. The Company also announced the resignation of Dr. Wenyi Gu from the Board upon completion of his term as an Australia-based non-executive director. 'On behalf of the management team and Board, I am delighted to welcome David and Gregory to the Company' commented John Seaberg, Chairman of Anteris. 'On the heels of our Q4 2024 listing onto NASDAQ, and as we ramp-up activities to launch the DurAVR® THV global, pivotal clinical trial (the "PARADIGM Trial"), we are excited to enhance the leadership team with two highly accomplished, U.S. based, healthcare executives as the company transitions to its next phase of growth. I also wish to extend gratitude to Dr. Gu for his commitment and contributions to the company over the course of his tenure as a member of the Board and wish him well on his future endeavors.' Mr. David Roberts is currently President of LeMaitre Vascular, Inc. (NASDAQ: LMAT), a position he has held since 2007. He joined LeMaitre in 1997 as Vice President of Business Development and was promoted to Chief Financial Officer in 2000. Prior to LeMaitre, Mr. Roberts served as Vice President of Development for BUCA, Inc. from 1994 to 1997, and prior to that as Associate of HarbourVest Partners from 1992 to 1994. Mr. Roberts received a Bachelor of Arts in Business Economics and History from Brown University and a Master of Business Administration from the Stanford University Graduate School of Business. Mr. Roberts serves as a director of LeMaitre Vascular, Inc., Lexington Medical, Inc. and Parasole Restaurant Holdings, Inc. Mr. Gregory Moss serves as Chief Business and Legal Officer, as well as Corporate Secretary and Chief Compliance Officer of Evommune, Inc. Prior to Evommune, Mr. Moss served as Executive Vice President, General Counsel, and Corporate Secretary, Chief Compliance Officer at Kadmon, a Sanofi Company, where he led legal, compliance, and business development operations, culminating in Kadmon's $1.9 billion acquisition in 2021. Prior to joining Kadmon in 2012, Mr. Moss served as a solicitor in the corporate risk department of a large Australian law firm and as an associate at a boutique law firm and hedge fund in New York, where he focused on complex litigation and event-driven outcomes. Mr. Moss currently serves on the board of Vitls, Inc. Mr. Moss earned a BA and an LLB from Macquarie University, Australia, and is a member of the Bar Associations of New York, USA, and New South Wales, Australia, with admissions before the Supreme Court of the United States of America; Southern District of New York; Supreme Court of New South Wales, Australia; and High Court of Australia. Mr. Roberts and Mr. Moss will help guide Anteris through its next phase of growth, with the upcoming global pivotal PARADIGM study in 3Q2025 towards the ultimate U.S. and EMA licensure of the DurAVR® THV for patients with aortic stenosis. About Anteris Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients. Anteris' lead product, the DurAVR® Transcatheter Heart Valve (THV), was designed in partnership with the world's leading interventional cardiologists and cardiac surgeons to treat aortic stenosis – a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR® THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. DurAVR® THV is made using a single piece of molded ADAPT® tissue, Anteris' patented anti-calcification tissue technology. ADAPT® tissue, which is FDA-cleared, has been used clinically for over 10 years and distributed for use in over 55,000 patients worldwide. The DurAVR® THV System is comprised of the DurAVR® valve, the ADAPT® tissue, and the balloon-expandable ComASUR® Delivery System. For more information: Investor Relations investor@ OrmsbyAnteris Technologies Global Corp.+61 1300 550 310 | +61 7 3152 3200 Investor Relations (US)mchatterjee@ Chatterjee, Life Science Group+1 917 330 4269WebsiteXFacebookLinkedIn
Yahoo
4 hours ago
- Yahoo
EVA AIR AND THE SAN FRANCISCO GIANTS TEAMED UP TO CELEBRATE HELLO KITTY® DAY AT ORACLE PARK
Co-branded jerseys, mascot appearances, and premium ticket giveaways highlighted the unique gameday. SAN FRANCISCO, June 9, 2025 /PRNewswire/ -- EVA Air was proud to join fans at Oracle Park on Sunday, June 8 for a special Hello Kitty®-themed gameday experience in partnership with the San Francisco Giants. From limited-edition collectibles to a special giveaway, in-game features and live activations, the promotion offered fans of all ages a fun-filled afternoon at the ballpark. Prior to game time, fans stopped by the EVA Air booth to enjoy interactive activities and branded giveaways. EVA Air President Clay Sun threw out the ceremonial first pitch and was joined on the field by two uniformed EVA Air flight attendants. EVA Air hosted a special giveaway during an inning break, where one lucky fan took home two Premium Economy flight tickets. The winner will have the chance to visit one destination from EVA Air's Asian routes, which include cities in Taiwan, and Southeast Asia like Bangkok, Bali, Manila, and Ho Chi Minh City, as well as Japan, South Korea, Hong Kong, Macao, and mainland China. "As a global carrier, we see immense value in partnerships that go beyond the terminal," said EVA Air President Clay Sun. "Since 2023, our collaboration with the San Francisco Giants has allowed us to connect with fans in dynamic and high-impact ways. This special game is a great example of how we continue to show up, with a continued commitment to creating standout experiences both in the skies and on the ground." "At the Giants, we are intentional about building partnerships that engage our fans and elevate the reach and relevance of both our team and our partner brands," said Steve Tseng, Senior Vice President, Partnerships at the San Francisco Giants. "Partnering with EVA Air and collaborating with Hello Kitty® allows us to reach our diverse fanbase in meaningful ways and continue to create unique experiences at Oracle Park." The first 15,000 fans who entered Oracle Park on June 8 received a co-branded Hello Kitty® Giants jersey featuring the EVA Air logo. Hello Kitty® also made a special appearance, joining the San Francisco Giants' mascot Lou Seal on the field. For more information and to learn more about EVA Air's services, visit About EVA Air:A Star Alliance member, EVA Air was founded in 1989 as Taiwan's first privately owned international airline. It is an affiliated company to global container-shipping leader Evergreen Line. It flies a fleet of more than 80 Boeing and Airbus aircraft to around 60 international destinations throughout Asia, Oceania, Europe and North America, with gateways in Los Angeles, San Francisco, Seattle, Chicago, Houston, New York, Toronto and Vancouver. Travelers can learn more about EVA and schedule, book and buy tickets at About San Francisco GiantsOne of the oldest teams in Major League Baseball, the 142-year old franchise moved to San Francisco from New York in 1958. After playing a total of 42 years in Seals Stadium and Candlestick Park, the team moved to the privately constructed, downtown ballpark on the corner of 3rd and King in 2000. The organization is widely recognized for its innovative business practices and baseball excellence having been named in the past decade the Sports Organization of the Year by Street & Smith's Sports Business Journal, Organization of the Year by Baseball America and ESPN's Sports Humanitarian Team of the Year. Oracle Park is also the only ballpark in the country to have earned Silver, Gold and Platinum LEED certification for an existing building. Since opening its gates, Oracle Park has become internationally-renowned as a premier venue in the world of both sports and entertainment. On the diamond, more than 75 million spectators have witnessed countless magical moments, including three World Series Championships (2010, 2012 & 2014), the raising of four National League Pennants and eight playoff appearances. The ballpark has also hosted some of music's biggest acts, including Lady Gaga, Beyoncé & Jay Z, Ed Sheeran, the Rolling Stones, the Eagles, Bruce Springsteen and the E-Street Band, Green Day and Billy Joel. View original content to download multimedia: SOURCE EVA Airways Corporation
